Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing

14d ago, source:

Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including ...

Century Therapeutics raises $60M, acquires Boston life sciences company

14d ago, source:

The acquisition and fundraising round will support the cell therapy company's operations and expand its product pipeline.

How Much Upside is Left in Century Therapeutics, Inc. (IPSC)? Wall Street Analysts Think 193.4%

1mon ago, source: Hosted on MSN

S hares of Century Therapeutics, Inc. (IPSC) have gained 9.7% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short ...

Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

3d ago, source:

PHILADELPHIA, April 23, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and ...

Century Therapeutics: Hold Rating Justified Amid Strategic Acquisition and Ongoing Clinical Trials

15d ago, source: Business Insider

Sami Corwin, an analyst from William Blair, has initiated a new Hold rating on Century Therapeutics (IPSC). Sami Corwin has given his Hold rating due to a combination of factors surrounding ...

Century Therapeutics gets grant for universal chimeric antigen receptor system with adaptable receptor specificity

11d ago, source: Pharmaceutical Technology

Revolutionize disease treatment with Century Therapeutics' patented universal chimeric antigen receptor system. Discover how this adaptable system uses immune effector cells and soluble polypeptides ...

PTC Therapeutics: Q1 Earnings Snapshot

19h ago, source:

(PTCT) on Thursday reported a loss of $91.6 million in its first quarter. The South Plainfield, New Jersey-based company said it had a loss of $1.20 per share. The results exceeded Wall Street ...

Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing

14d ago, source: Hosted on MSN

Century announced pipeline and platform enhancements through the acquisition of Clade Therapeutics Inc., a privately held biotech company focused on discovering and delivering engineerable ...

Century Therapeutics Inc IPSC

22d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Century Therapeutics Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...